Cipher Pharmaceuticals Statistics

Total Valuation

Cipher Pharmaceuticals has a market cap or net worth of 249.41 million. The enterprise value is 278.82 million.

Market Cap	249.41M
Enterprise Value	278.82M

Important Dates

The next estimated earnings date is Friday, March 14, 2025.

Earnings Date	Mar 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-2.82%
Shares Change (QoQ)	+4.58%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	14.83M

Valuation Ratios

The trailing PE ratio is 15.73.

PE Ratio	15.73
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 23.38, with an EV/FCF ratio of -4.16.

EV / Earnings	17.58
EV / Sales	11.19
EV / EBITDA	23.38
EV / EBIT	29.95
EV / FCF	-4.16

Financial Position

The company has a current ratio of 2.00, with a Debt / Equity ratio of 0.41.

Current Ratio	2.00
Quick Ratio	1.57
Debt / Equity	0.41
Debt / EBITDA	3.22
Debt / FCF	-0.61
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 17.98% and return on invested capital (ROIC) is 5.68%.

Return on Equity (ROE)	17.98%
Return on Assets (ROA)	5.06%
Return on Capital (ROIC)	5.68%
Revenue Per Employee	5.29M
Profits Per Employee	3.17M
Employee Count	5
Asset Turnover	0.22
Inventory Turnover	1.30

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +131.99% in the last 52 weeks. The beta is 1.17, so Cipher Pharmaceuticals's price volatility has been higher than the market average.

Beta (5Y)	1.17
52-Week Price Change	+131.99%
50-Day Moving Average	10.19
200-Day Moving Average	9.10
Relative Strength Index (RSI)	46.01
Average Volume (20 Days)	14,339

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cipher Pharmaceuticals had revenue of 26.46 million and earned 15.86 million in profits. Earnings per share was 0.63.

Revenue	26.46M
Gross Profit	21.38M
Operating Income	9.88M
Pretax Income	9.49M
Net Income	15.86M
EBITDA	12.57M
EBIT	9.88M
Earnings Per Share (EPS)	0.63

Full Income Statement

Balance Sheet

The company has 9.52 million in cash and 40.75 million in debt, giving a net cash position of -31.23 million.

Cash & Cash Equivalents	9.52M
Total Debt	40.75M
Net Cash	-31.23M
Net Cash Per Share	n/a
Equity (Book Value)	98.86M
Book Value Per Share	3.86
Working Capital	14.55M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 13.08 million and capital expenditures -80.06 million, giving a free cash flow of -66.98 million.

Operating Cash Flow	13.08M
Capital Expenditures	-80.06M
Free Cash Flow	-66.98M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 80.78%, with operating and profit margins of 37.35% and 59.92%.

Gross Margin	80.78%
Operating Margin	37.35%
Pretax Margin	35.86%
Profit Margin	59.92%
EBITDA Margin	47.52%
EBIT Margin	37.35%
FCF Margin	n/a

Dividends & Yields

Cipher Pharmaceuticals does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.82%
Shareholder Yield	2.82%
Earnings Yield	6.36%
FCF Yield	-26.86%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cipher Pharmaceuticals has an Altman Z-Score of 2.86. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.86
Piotroski F-Score	n/a